Confirming Helicobacter pylori eradication after treatment
What it is
After treatment for H. pylori, eradication has to be confirmed by a test. Follow-up noninvasive testing to confirm HP eradication should be performed at least 4 weeks after completion of therapy, in any patient with a positive H. pylori test result. The stance is now broad: all H. pylori-infected individuals should be treated regardless of symptoms, given the link to gastric cancer.
How it is diagnosed
The methods split into invasive and non-invasive:
- Invasive, at EGD: rapid urease test (RUT, the CLO test), sensitivity 75-98% with specificity 70-98%; culture, sensitivity 70-92% with specificity 100%; histology, sensitivity 93-99% with specificity 95-99%
- Non-invasive: stool antigen test (SAT), sensitivity 89-96% with specificity 87-94%; serology (ELISA), sensitivity 88-99% with specificity 86-99%; 13C-urea breath test, sensitivity 95% and specificity 95-99%
Culture is marked as the golden best test, but not practical. Usually go for a non-invasive test if there is no indication for EGD. High risk goes invasive; a young and asymptomatic patient at low risk goes non-invasive. When you test is part of the test. Check at least 4 weeks after completion of therapy, and before testing stop the PPI for 2 weeks and the antibiotic for 4-6 weeks.
What can go wrong
Serologic HP testing should not be used to confirm H. pylori eradication, because it can remain positive without active infection: a positive serology can indicate a previous infection. It is the least sensitive of the tests for follow-up after treatment, so it is not the one to pick. Follow-up EGD for gastric ulcers is indicated only if the patient remains symptomatic after treatment, the cause is uncertain, or biopsies were not performed during the initial upper endoscopy. Duodenal PUD without complications does not require follow-up EGD.